Circulating exosomal miR-92b: Its role for cancer immunoediting and clinical value for prediction of posttransplant hepatocellular carcinoma recurrence
Toshiaki Nakano(Kaohsiung Medical University), Chao‐Long Chen, Kuang‐Tzu Huang(New York University), Tsung‐Hui Hu(National Sun Yat-sen University), Chih‐Che Lin(Kaohsiung Chang Gung Memorial Hospital), Shigeru Goto(Kaohsiung Chang Gung Memorial Hospital), Lung‐Chih Li(Kaohsiung Chang Gung Memorial Hospital), Chih‐Chi Wang(Kaohsiung Chang Gung Memorial Hospital), I‐Hsuan Chen(Kaohsiung Chang Gung Memorial Hospital), Po‐Jung Chen(Chang Gung University), Yu‐Fan Cheng, Hui‐Peng Tseng(Chang Gung University)
Cited by 115
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Hepatogastroenterology
|Hepatogastroenterology|2012|536
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
|Gastroenterology|2007|232
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|Liver International|2016|221
Clinical characteristics and prognostic factors of splenic abscess: A review of 67 cases in a single medical center of Taiwan
|World Journal of Gastroenterology|2006|217